ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,395Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 122

$431K Total Retail Price of All Prescriptions

Rank: 25 out of 122

281 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 281 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

7% of this provider’s 281 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 6,108 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
LEVOTHYROXINE SODIUM 269 253 1 4
LISINOPRIL 228 228 2 2
SERTRALINE HCL 206 204 3 18
OMEPRAZOLE 205 196 4 3
SIMVASTATIN 190 190 5 1
AMLODIPINE BESYLATE 166 162 6 7
TRAMADOL HCL 154 153 7 20
WARFARIN SODIUM 152 152 8 9
RISPERIDONE 149 149 9 64
QUETIAPINE FUMARATE 145 145 10 46
DONEPEZIL HCL 144 144 11 25
FUROSEMIDE 138 136 12 5
LOVASTATIN 123 118 13 28
CITALOPRAM HBR 108 99 14 15
NAMENDA 100 100 15 65
HYDROCHLOROTHIAZIDE 100 100 15 6
ATENOLOL 88 84 17 10
GABAPENTIN 82 77 18 12
ALENDRONATE SODIUM 79 79 19 35
METOPROLOL TARTRATE 79 75 19 8
METFORMIN HCL 78 78 21 14
ATORVASTATIN CALCIUM 77 73 22 13
MIRTAZAPINE 74 74 23 61
TRAZODONE HCL 72 63 24 21
METOPROLOL SUCCINATE 69 68 25 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 61 26 49
PROAIR HFA 63 49 27 31
PREDNISONE 57 55 28 24
HYDROCODONE-ACETAMINOPHEN 55 45 S3 29 16
CYMBALTA 53 52 30 62
ESCITALOPRAM OXALATE 51 49 31 59
IBUPROFEN 50 50 32 68
VENLAFAXINE HCL ER 50 50 32 54
TRIAMTERENE-HCTZ 50 50 32 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.